Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer
- PMID: 6215982
Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical